Glycopyrolate and Neostigmin 0.5 mg/2.5 mg Injection
Marketer
Troikaa Pharmaceuticals Ltd
Salt Composition
Glycopyrrolate (0.5mg) + Neostigmine (2.5mg)
Overview Glycopyrolate and Neostigmin 0.5 mg/2.5 mg Injection
A combined injection of glycopyrolate (0.5mg) and neostigmine (2.5mg) is administered during surgical procedures to manage anesthesia. This medication is given intravenously by a medical professional, with the dosage tailored to individual patient needs and response. Complete disclosure of all other medications to your healthcare provider is essential, as interactions are possible. Although generally well-tolerated, allergic reactions are the most frequently reported adverse effect, typically resolving spontaneously. However, seek immediate medical attention if you experience any concerning side effects. Drowsiness and dizziness are also possible, necessitating avoidance of driving or activities demanding alertness until the drug's impact is known. Alcohol consumption should be avoided due to potential exacerbation of dizziness. Prior to treatment, inform your physician of any existing kidney, liver, or gastrointestinal conditions, or if you are pregnant, considering pregnancy, or breastfeeding, to ensure appropriate dosage and management.
Uses of Glycopyrolate and Neostigmin 0.5 mg/2.5 mg Injection
Countering the impact of specific surgical anesthetics
Major Benefits of Glycopyrolate and Neostigmin 0.5 mg/2.5 mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Glycopyrolate and Neostigmin 0.5 mg/2.5 mg Injection:
- Allergic reaction
How to use Glycopyrolate and Neostigmin 0.5 mg/2.5 mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Glycopyrolate and Neostigmin 0.5 mg/2.5 mg Injection works:
Glycopyrrolate and neostigmine methylsulfate injection (0.5 mg/2.5 mg) contains glycopyrrolate and neostigmine.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Glycopyrolate and Neostigmine injection (0.5 mg/2.5 mg) and alcohol can result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Glycopyrolate and Neostigmine 0.5 mg/2.5 mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
The combined Glycopyrolate and Neostigmin 0.5 mg/2.5 mg injection is likely safe for breastfeeding mothers. Available evidence in humans indicates minimal infant risk. However, prolonged use of this injection may decrease breast milk supply.
DrivingUNSAFE
Administering Glycopyrolate and Neostigmine 0.5 mg/2.5 mg Injection can induce adverse reactions impacting driving capabilities. Visual disturbances and impaired coordination, resulting from this injection, may compromise safe driving.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Glycopyrolate and Neostigmine 0.5 mg/2.5 mg Injection. Dosage modification may be necessary. Physician consultation is recommended. Routine monitoring of renal function and certain blood parameters may be advised during treatment.
LiverSAFE IF PRESCRIBED
The combined Glycopyrolate and Neostigmin 0.5 mg/2.5 mg injection appears safe for individuals with hepatic impairment. Current evidence indicates dose modification might be unnecessary in this population, though data are limited. Physician consultation is recommended.
What if you forget to take Glycopyrolate and Neostigmin 0.5 mg/2.5 mg Injection :
Omit a dose of Glycopyrolate and Neostigmine 0.5 mg/2.5 mg Injection? Seek your physician's advice.
Facts to Know About Glycopyrolate and Neostigmin 0.5 mg/2.5 mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience |
3,018 People bought this recently